0001192482-21-000433.txt : 20210517 0001192482-21-000433.hdr.sgml : 20210517 20210517160706 ACCESSION NUMBER: 0001192482-21-000433 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210420 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berelowitz Michael CENTRAL INDEX KEY: 0001493383 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 21930486 MAIL ADDRESS: STREET 1: 415 EAST 37TH STREET STREET 2: APT 36C CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 770-534-8239 MAIL ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 4/A 1 edgar.xml PRIMARY DOCUMENT X0306 4/A 2021-04-20 2021-04-22 0001588972 Recro Pharma, Inc. REPH 0001493383 Berelowitz Michael C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 1 0 0 0 Stock Option (right to buy) 2.6 2021-04-20 4 A 0 38012 0 A 2031-04-20 Common Stock 38012 38012 D This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021. The stock option will vest on April 20, 2022. /s/ Ryan D. Lake, Attorney-in-fact 2021-05-17